Genetic basis of kainate-induced excitotoxicity in mice: Phenotypic modulation of seizure-induced cell death

Epilepsy Research

Volumn 55, Issue 3, 2003, Pages 201-210

  Schauwecker, Paula Elyse ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Epilepsy; Excitotoxicity; Hippocampus; Kainic acid; Mouse strain

Indexed keywords

KAINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACKCROSSING; BRAIN CELL; CELL DEATH; GENE LOCUS; GENETIC TRAIT; GENOTYPE; HEREDITY; HYBRID; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEIZURE; STRAIN DIFFERENCE;

EID: 0041324719     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(03)00115-3     Document Type: Article

References (45)

1. Beal M.F. Mechanisms of excitotoxicity in neurologic diseases. FASEB J. 6:1992;3338-3344.
2. Ben-Ari Y., Cossart R. Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci. 23:2000;580-587.
3. Ben-Ari Y., Tremblay E., Riche D., Ghilini G., Niquet R. Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentylenetetrazole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience. 6:1981;1361-1391.
4. Ben-Ari Y., Tremblay E., Berger M., Nitecka L. Kainic acid seizure syndrome and binding sites in developing rats. Brain Res. 316:1984;284-288.
5. Choi D.W. Ischemia-induced neuronal apoptosis. Curr. Opin. Neurobiol. 6:1996;667-672.
6. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988a;623-634.
7. Choi D.W. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11:1988b;465-469.
8. Coyle J.T. Neurotoxic action of kainic acid. J. Neurochem. 41:1983;1-11.
9. Doble A. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol. Ther. 81:1999;163-221.
10. Ferraro T.N., Golden G.T., Smith G.G., Berrettini W.H. Differential vulnerability to seizures induced by systemic kainic acid treatment in mature DBA/2J and C57BL/6J mice. Epilepsia. 36:1995;301-307.
11. Ferraro T.N., Golden G.T., Smith G.G., Schork N.H., St. Jean P., Ballas C., Choi H., Berrettini W.H. Mapping murine loci for seizure response to kainic acid. Mamm. Genome. 8:1997;200-208.
12. Fink R.P., Heimer L. Two methods for selective impregnation of degeneration axons and their synaptic endings in the central nervous system. Brain Res. 4:1967;369-376.
13. Fujikawa D.G. The neuroprotective effect of ketamine administered after status epilepticus onset. Epilepsia. 36:1995;186-195.
14. Fujikawa D.G. The temporal evolution of neuronal damage from pilocarpine-induced status epilepticus. Brain Res. 725:1996;11-22.
15. Fujikawa D.G., Daniels A.H., Kim J.S. The competitive NMDA-receptor antagonist CGP 40116 protects against status epilepticus-induced neuronal damage. Epilepsy Res. 17:1994;207-219.
16. Holmes G.L., Thompson J.L. Effects of kainic acid on seizure susceptibility in the developing brain. Brain Res. 467:1988;51-59.
17. Jarrard L.E., Meldrum B.S. Selective excitotoxic pathology in the rat hippocampus. Neuropathol. Appl. Neurobiol. 19:1993;381-389.
18. Lander E.S., Botstein D. Mapping Mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics. 121:1989;185-199.
19. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330:1994;613-622.
20. Mattson, M.P., Mark, R.J., 1996. Cellular and molecular mechanisms of ischemic brain damage. In: Siesjö, B.K., Wieloch, T. (Eds.), Advances in Neurology. Lippincott-Raven, Philadelphia, pp. 1-35.
21. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11:1990;379-387.
22. Nadler J.V., Cuthbertson G.J. Kainic acid neurotoxicity toward hippocampal formation: dependence on specific excitatory pathways. Brain Res. 195:1980;47-56.
23. Nadler J.V., Evenson D.A. Use of excitatory amino acids to make axon-sprouting lesions of hypothalamus. Methods Enzymol. 103:1983;393-400.
24. Nadler J.V., Perry B.W., Gentry C., Cotman C.W. Loss and reacquisition of hippocampal synapses after selective destruction of CA3-CA4 afferents with kainic acid. Brain Res. 191:1980;387-403.
25. Neuhaus I.M., Sommardahl C.S., Johnson D.K., Beier D.R. Microsatellite DNA variants between the FVB/N and C3H3B/FeJLe and C57BL/6J mouse strains. Mamm. Genome. 8:1997;506-509.
26. Nitecka L., Tremblay E., Charton G., Bouillot J.P., Berger M.L., Ben-Ari Y. Neuroscience. 13:1984;1073-1094.
27. Olney J.W. Excitatory amino acids and neuropsychiatric diseases. Biol. Psychiatry. 26:1989;505-525.
28. Olney J.W., Price M.T., Samson L., Labruyere J. The role of specific ions in glutamate neurotoxicity. Neurosci. Lett. 65:1986;65-71.
29. Paterson A.H., Lander E.S., Hewitt J.D., Peterson S., Lincoln S.E., Tanksley S.D. Resolution of quantitative traits into Mendelian factors by using a complete linkage map of restriction fragment length polymorphisms. Nature. 335:1988;721-726.
30. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32:1972;281-294.
31. Rothman S.M. Excitotoxins: possible mechanisms of action. Ann. N.Y. Acad. Sci. 648:1992;132-139.
32. Rothman S.M., Olney J.W. Excitotoxicity and the NMDA receptor. Trends Neurosci. 10:1987;299-302.
33. Schauwecker P.E., Ramirez J.J., Steward O. Genetic dissection of the signals that induce synaptic reorganization. Exp. Neurol. 161:2000;139-152.
34. Schauwecker P.E. Seizure-induced neuronal death is associated with induction of c-Jun N-terminal kinase and is dependent on genetic background. Brain Res. 884:2000;116-128.
35. Schauwecker P.E. Complications associated with genetic background effects in models of experimental epilepsy. Prog. Brain Res. 135:2002a;139-148.
36. Schauwecker P.E. Modulation of cell death by mouse genotype: differential vulnerability to excitatory amino acid-induced lesions. Exp. Neurol. 178:2002b;219-235.
37. Schauwecker P.E. Differences in ionotropic glutamate receptor subunit expression are not responsible for strain-dependent susceptibility to excitotoxin-induced injury. Mol. Brain Res. 112:2003;70-81.
38. Schauwecker P.E., Steward O. Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. Proc. Natl. Acad. Sci. U.S.A. 94:1997;4103-4108.
39. Schmued L.C., Hopkins K.J. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874:2000;123-130.
40. Sperk G., Lassmann H., Baran H., Kish S.J., Seittelberger F., Hornykiewicz O. Kainic acid-induced seizures: neurochemical and histopathological changes. Neuroscience. 10:1983;1301-1315.
41. Stafstrom C.E., Thompson J.L., Holmes G.L. Kainic acid seizures in the developing brain: status epilepticus and spontaneous recurrent seizures. Dev. Brain Res. 65:1992;227-236.
42. Taketo M., Schroeder A.C., Mobraaten L.E., Gunning K.B., Hanten G., Fox R.R., Roderick T.H., Stewart C.L., Lilly F., Hansen C.T., Overbeek P.A. FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc. Natl. Acad. Sci. U.S.A. 88:1991;2065-2069.
43. Taylor, B.A., 1978. In: Morse, H.C. (Ed.), Origins of Inbred Mice. Academic Press, New York, pp. 423-438.
44. Tremblay E., Nitecka L., Berger M.L., Ben-Ari Y. Maturation of kainic acid seizure-brain damage system in the rat. I. Clinical, electrographic, and metabolic observations. Neuroscience. 13:1984;1051-1072.
45. Wozniak D.F., Stewart G.R., Miller J.P., Olney J.W. Age-related sensitivity to kainate neurotoxicity. Exp. Neurol. 114:1991;250-253.